Ownership

Justin J. McAnear - Insider Trading & Ownership

Entity: Individual
Location: 10 X Genomics, Inc., 6230 Stoneridge Mall Road, Pleasanton, CA
Summary: The estimated net worth of Justin J. McAnear is at least $3.23M dollars as of August 26, 2024. Justin J. McAnear is the Former Chief Financial Officer of 10x Genomics, Inc. and owns shares of 10x Genomics, Inc. (TXG) stock worth about $3.23M.
All Insider Reports: All Insider Reports

Ownership of Justin J. McAnear

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
TXG	10x Genomics, Inc.	Former Chief Financial Officer	$3.23M	-$138K	-4.1%	Aug 22, 2024

Showing 1 to 1 of 1 entries

Insider Transactions Reported by Justin J. McAnear:

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership
TXG	10x Genomics, Inc.	Class A Common Stock	Sale	-2.03%	-$66.7K	22.53	-2.96K	143K	8/22/2024	Direct
TXG	10x Genomics, Inc.	Class A Common Stock	Sale	-1.97%	-$71.4K	24.30	-2.94K	146K	5/22/2024	Direct
TXG	10x Genomics, Inc.	Class A Common Stock	Award	+56%	$0	0.00	+53.3K	149K	3/21/2024	Direct
TXG	10x Genomics, Inc.	Class A Common Stock	Sale	-1.92%	-$86.4K	46.34	-1.87K	95.2K	2/22/2024	Direct
TXG	10x Genomics, Inc.	Class A Common Stock	Sale	-1.7%	-$72.8K	43.34	-1.68K	97.1K	11/22/2023	Direct
TXG	10x Genomics, Inc.	Class A Common Stock	Sale	-1.67%	-$76.8K	45.78	-1.68K	98.8K	8/22/2023	Direct
TXG	10x Genomics, Inc.	Class A Common Stock	Sale	-1.63%	-$91.7K	55.06	-1.67K	100K	5/23/2023	Direct
TXG	10x Genomics, Inc.	Class A Common Stock	Award	+34.4%	$0	0.00	+26K	102K	3/21/2023	Direct
TXG	10x Genomics, Inc.	Stock Option (right to buy)	Award		$0	0.00	+26K	26K	3/21/2023	Direct
TXG	10x Genomics, Inc.	Performance based Restricted Stock Units	Award		$0	0.00	+13K	13K	3/21/2023	Direct
TXG	10x Genomics, Inc.	Class A Common Stock	Sale	-1.62%	-$59.5K	47.75	-1.25K	75.5K	2/22/2023	Direct
TXG	10x Genomics, Inc.	Class A Common Stock	Sale	-2.07%	-$55.4K	34.07	-1.63K	76.8K	11/22/2022	Direct
TXG	10x Genomics, Inc.	Class A Common Stock	Award	+34.9%	$0	0.00	+20.3K	78.4K	9/14/2022	Direct
TXG	10x Genomics, Inc.	Performance-based Restricted Stock Units	Award		$0	0.00	+40.6K	40.6K	9/14/2022	Direct
TXG	10x Genomics, Inc.	Stock Option (right to buy)	Award		$0	0.00	+40.6K	40.6K	9/14/2022	Direct
TXG	10x Genomics, Inc.	Class A Common Stock	Sale	-1.67%	-$34.7K	35.19	-987	58.1K	8/23/2022	Direct
TXG	10x Genomics, Inc.	Class A Common Stock	Sale	-1.61%	-$47.2K	48.76	-967	59.1K	5/23/2022	Direct
TXG	10x Genomics, Inc.	Class A Common Stock	Purchase	+0.26%	$6.4K	40.49	+158	60K	5/13/2022	Direct
TXG	10x Genomics, Inc.	Class A Common Stock	Award	+55.4%	$0	0.00	+21.4K	59.9K	3/22/2022	Direct
TXG	10x Genomics, Inc.	Stock Option (Right to Buy)	Award		$0	0.00	+53.4K	53.4K	3/22/2022	Direct
TXG	10x Genomics, Inc.	Class A Common Stock	Sale	-0.74%	-$22.6K	78.60	-288	38.5K	2/22/2022	Direct
TXG	10x Genomics, Inc.	Class A Common Stock	Sale	-20.5%	-$1.46M	146.07	-10K	38.8K	1/3/2022	Direct
TXG	10x Genomics, Inc.	Class A Common Stock	Options Exercise	+25.8%	$50.4K	5.04^*	+10K	48.8K	1/3/2022	Direct
TXG	10x Genomics, Inc.	Stock Option (right to buy)	Options Exercise	-2.78%	$0	0.00	-10K	350K	1/3/2022	Direct
TXG	10x Genomics, Inc.	Class A Common Stock	Sale	-20.5%	-$1.48M	147.75	-10K	38.8K	12/1/2021	Direct
TXG	10x Genomics, Inc.	Class A Common Stock	Options Exercise	+25.8%	$50.4K	5.04^*	+10K	48.8K	12/1/2021	Direct
TXG	10x Genomics, Inc.	Stock Option (right to buy)	Options Exercise	-2.7%	$0	0.00	-10K	360K	12/1/2021	Direct
TXG	10x Genomics, Inc.	Class A Common Stock	Sale	-0.72%	-$41.7K	148.38	-281	38.8K	11/22/2021	Direct
TXG	10x Genomics, Inc.	Class A Common Stock	Options Exercise	+25.6%	$50.4K	5.04^*	+10K	49.1K	11/1/2021	Direct
TXG	10x Genomics, Inc.	Class A Common Stock	Sale	-20.4%	-$1.64M	163.54	-10K	39.1K	11/1/2021	Direct
TXG	10x Genomics, Inc.	Stock Option (right to buy)	Options Exercise	-2.63%	$0	0.00	-10K	370K	11/1/2021	Direct
TXG	10x Genomics, Inc.	Class A Common Stock	Options Exercise	+25.6%	$50.4K	5.04^*	+10K	49.1K	10/1/2021	Direct
TXG	10x Genomics, Inc.	Class A Common Stock	Sale	-20.4%	-$1.44M	143.52	-10K	39.1K	10/1/2021	Direct
TXG	10x Genomics, Inc.	Stock Option (right to buy)	Options Exercise	-2.56%	$0	0.00	-10K	380K	10/1/2021	Direct
TXG	10x Genomics, Inc.	Class A Common Stock	Options Exercise	+25.6%	$50.4K	5.04^*	+10K	49.1K	9/1/2021	Direct
TXG	10x Genomics, Inc.	Class A Common Stock	Sale	-20.4%	-$1.77M	177.49	-10K	39.1K	9/1/2021	Direct
TXG	10x Genomics, Inc.	Stock Option (right to buy)	Options Exercise	-2.5%	$0	0.00	-10K	390K	9/1/2021	Direct
TXG	10x Genomics, Inc.	Class A Common Stock	Sale	-0.69%	-$43.7K	161.85	-270	39.1K	8/23/2021	Direct
TXG	10x Genomics, Inc.	Class A Common Stock	Options Exercise	+25.4%	$50.4K	5.04^*	+10K	49.4K	8/2/2021	Direct
TXG	10x Genomics, Inc.	Class A Common Stock	Sale	-20.3%	-$1.8M	180.38	-10K	39.4K	8/2/2021	Direct
TXG	10x Genomics, Inc.	Stock Option (right to buy)	Options Exercise	-2.44%	$0	0.00	-10K	400K	8/2/2021	Direct
TXG	10x Genomics, Inc.	Class A Common Stock	Options Exercise	+25.4%	$50.4K	5.04^*	+10K	49.4K	7/1/2021	Direct
TXG	10x Genomics, Inc.	Class A Common Stock	Sale	-20.3%	-$1.92M	191.56	-10K	39.4K	7/1/2021	Direct
TXG	10x Genomics, Inc.	Stock Option (right to buy)	Options Exercise	-2.38%	$0	0.00	-10K	410K	7/1/2021	Direct
TXG	10x Genomics, Inc.	Class A Common Stock	Options Exercise	+25.6%	$50.4K	5.04^*	+10K	49K	6/1/2021	Direct
TXG	10x Genomics, Inc.	Class A Common Stock	Sale	-20.4%	-$1.74M	174.41	-10K	39K	6/1/2021	Direct
TXG	10x Genomics, Inc.	Stock Option (right to buy)	Options Exercise	-2.32%	$0	0.00	-10K	420K	6/1/2021	Direct
TXG	10x Genomics, Inc.	Class A Common Stock	Sale	-0.72%	-$45.7K	162.66	-281	39K	5/24/2021	Direct
TXG	10x Genomics, Inc.	Class A Common Stock	Award	+29.4%	$0	0.00	+8.94K	39.3K	3/19/2021	Direct
TXG	10x Genomics, Inc.	Stock Option (right to buy)	Award		$0	0.00	+22.3K	22.3K	3/19/2021	Direct

Previous1Next

Showing 1 to 50 of 50 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.